CareDx (CDNA) Lags Q2 Earnings and Revenue Estimates

Core Insights - CareDx reported quarterly earnings of $0.1 per share, missing the Zacks Consensus Estimate of $0.12 per share, and down from $0.25 per share a year ago, representing an earnings surprise of -16.67% [1] - The company posted revenues of $86.68 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 4.45%, and down from $92.27 million year-over-year [2] - CareDx shares have declined approximately 40% since the beginning of the year, contrasting with the S&P 500's gain of 7.1% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.15 on revenues of $94.77 million, and for the current fiscal year, it is $0.60 on revenues of $371.5 million [7] - The estimate revisions trend for CareDx was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - The Medical Services industry, to which CareDx belongs, is currently in the top 30% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - Establishment Labs Holdings Inc., another company in the same industry, is expected to report a quarterly loss of $0.54 per share, with revenues anticipated to be $51.61 million, reflecting a 17% increase year-over-year [9][10]